| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $7.0M | +28.1% |
| SG&A Expense | $9.7M | -14.9% |
| Operating Income | -$21.6M | -28.8% |
| Pre-tax Income | -$19.8M | — |
| Income Tax | $0 | — |
| Net Income | -$19.8M | -97.8% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.6M | -32.4% |
| Current Assets | $3.0M | -32.0% |
| Total Assets | $50.6M | +1061.0% |
| Current Liabilities | $19.9M | +334.3% |
| Total Liabilities | $28.3M | +518.1% |
| Stockholders' Equity | $22.2M | +9807.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.6M | +23.6% |
| Investing Cash Flow | $382K | — |
| Financing Cash Flow | $11.0M | +56.5% |